Patent · US Active

Detection of lung neoplasia by amplification of RNA sequences

US12098431B2 · kind B2 · utility

0Cited by
50References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2022
Grant dateSep 24, 2024
Priority date
Expiry dateSep 15, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein is technology for lung neoplasia screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.